Cargando…
An Inter‐Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer
Oncolytic adenoviruses (Ads) have gained great attention in cancer therapy because they cause direct cytolytic infection and indirectly induce antitumor immunity. However, their efficacy is compromised by host antiviral immune response, poor tumor delivery, and the immunosuppressive tumor microenvir...
Autores principales: | Ding, Li, Gao, Qingqing, Xu, Zhuobin, Cai, Liangliang, Chen, Sujuan, Zhang, Xinyue, Cao, Peng, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805568/ https://www.ncbi.nlm.nih.gov/pubmed/34747156 http://dx.doi.org/10.1002/advs.202103470 |
Ejemplares similares
-
Emerging role of Natural killer cells in oncolytic virotherapy
por: Bhat, Rauf, et al.
Publicado: (2015) -
Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression
por: Nelson, Adam, et al.
Publicado: (2022) -
Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
por: Ghasemi, Matin, et al.
Publicado: (2023) -
An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
por: Li, Feiyu, et al.
Publicado: (2023) -
Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy
por: Wang, Xianwang, et al.
Publicado: (2023)